Published in World J Gastroenterol on January 14, 2014
Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome. Gastroenterol Res Pract (2014) 0.93
Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome. Acta Pharmacol Sin (2015) 0.84
Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. World J Gastrointest Endosc (2014) 0.84
Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance. Gastroenterol Res Pract (2015) 0.84
Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84
Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome. Mol Med Rep (2014) 0.83
Diet in irritable bowel syndrome. Nutr J (2015) 0.81
Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur J Clin Nutr (2015) 0.81
Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome. Eur J Clin Nutr (2014) 0.80
Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. World J Gastroenterol (2015) 0.79
Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol (2016) 0.79
Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance. Int J Mol Med (2016) 0.78
Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Exp Biol Med (Maywood) (2017) 0.76
Stomach antral endocrine cells in patients with irritable bowel syndrome. Int J Mol Med (2014) 0.76
Abnormalities in endocrine and immune cells are correlated in dextran‑sulfate‑sodium‑induced colitis in rats. Mol Med Rep (2016) 0.76
Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis. Mol Med Rep (2016) 0.75
The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J (2015) 0.75
The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats. Evid Based Complement Alternat Med (2017) 0.75
Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats. Mol Med Rep (2016) 0.75
Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease. World J Gastroenterol (2017) 0.75
Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75
Dietary fiber in irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75
Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome. BMC Gastroenterol (2017) 0.75
Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients (2017) 0.75
Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature (2007) 29.32
Functional bowel disorders. Gastroenterology (2006) 20.72
Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (1999) 17.72
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet (1998) 10.51
Functional bowel disorders in apparently healthy people. Gastroenterology (1980) 8.52
Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat (1974) 8.05
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Liver regeneration. Hepatology (2006) 7.52
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
The burden of selected digestive diseases in the United States. Gastroenterology (2002) 6.79
Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab (2001) 6.41
Non-colonic features of irritable bowel syndrome. Gut (1986) 5.48
Irritable bowel syndrome in the general population. BMJ (1992) 5.26
Regulation of early lung morphogenesis: questions, facts and controversies. Development (2006) 4.59
The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58
Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science (2003) 4.58
Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol (2010) 4.45
Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut (1973) 4.28
Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology (2000) 4.27
The intestinal stem cell. Genes Dev (2008) 4.21
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology (2004) 4.04
Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology (1995) 3.95
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86
Regulatory phases of early liver development: paradigms of organogenesis. Nat Rev Genet (2002) 3.79
The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol (2002) 3.59
Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology (2002) 3.50
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther (2003) 3.41
Peripheral mechanisms in irritable bowel syndrome. N Engl J Med (2012) 3.40
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut (2000) 3.26
The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25
Postinfectious irritable bowel syndrome. Gastroenterology (2009) 3.17
Postinfectious irritable bowel syndrome--a meta-analysis. Am J Gastroenterol (2006) 3.17
Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns. Gut (1983) 2.93
Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol (2002) 2.85
Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81
Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology (1987) 2.80
Organic and functional disorders in 2000 gastroenterology outpatients. Lancet (1983) 2.78
Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology (1990) 2.75
Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology (2009) 2.55
Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci (2002) 2.46
Ciliated epithelial cell lifespan in the mouse trachea and lung. Am J Physiol Lung Cell Mol Physiol (2008) 2.42
Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun (2000) 2.42
Functional abdominal pain: further evidence that whole gut is affected. Br Med J (Clin Res Ed) (1982) 2.41
Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut (1983) 2.39
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
Minireview: Development and differentiation of gut endocrine cells. Endocrinology (2004) 2.32
The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morphol (1973) 2.31
Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology (1995) 2.29
Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther (1999) 2.28
Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol (1998) 2.24
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
Abnormal small-bowel motility demonstrated by radiotelemetry in a patient with irritable colon. Lancet (1980) 2.19
Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet (1987) 2.13
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. Gut (1984) 2.11
International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol (2009) 2.06
Colonic myoelectric activity in the irritable bowel syndrome. Gastroenterology (1976) 2.05
Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract (2004) 2.03
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96
Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes (2008) 1.94
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2008) 1.93
Antroduodenal manometry. Usefulness and limitations as an outpatient study. Dig Dis Sci (1992) 1.93
Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.93
Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology (1983) 1.90
Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. Gastroenterology (1990) 1.89
Impact of irritable bowel syndrome on quality of life. Dig Dis Sci (1996) 1.81
Irritable bowel syndrome in twins: genes and environment. Gut (2006) 1.81
Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab (2006) 1.81
5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes (2013) 1.79
Prevalence of irritable bowel syndrome in Hong Kong. J Gastroenterol Hepatol (2002) 1.79
Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol (2001) 1.79
Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci (1996) 1.76
Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut (1993) 1.71
Irritable bowel syndrome in office-based practice in the United States. Gastroenterology (1991) 1.69
Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity. Dig Dis Sci (1995) 1.69
Diagnostic criteria for irritable bowel syndrome: utility and applicability in clinical practice. Digestion (2004) 1.69
Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology (1998) 1.66
Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc (2000) 1.64
Colonic motor and myoelectrical activity: a comparative study of normal subjects, psychoneurotic patients, and patients with irritable bowel syndrome. Gastroenterology (1981) 1.64
Oesophageal motility in the irritable bowel syndrome. Br Med J (Clin Res Ed) (1981) 1.63
Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil (2004) 1.63
Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol (2003) 1.62
Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther (2006) 1.61
Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut (2005) 1.60
Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther (2010) 1.59
Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc (1995) 1.58
Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut (1998) 1.57
Irritable bowel syndrome: a co-twin control analysis. Am J Gastroenterol (2007) 1.56
Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology (2007) 1.55
IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci (2004) 1.53
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes (2005) 1.52
Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology (1987) 1.52
Role of infection in irritable bowel syndrome. J Gastroenterol (2007) 1.50
Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut (2004) 1.50
Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology (2007) 1.48
The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community. Am J Gastroenterol (2004) 1.47
Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. World J Gastrointest Endosc (2014) 0.84